Skip to content

Single Incision Plus One Port Laparoscopic Surgery Assistant Enhanced Recovery After Surgery on Colorectal Cancer

Effect of Single Incision Plus One Port Laparoscopic Surgery Assistant Enhanced Recovery After Surgery on Colorectal Cancer : A Single Arm Trial

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04268290
Enrollment
120
Registered
2020-02-13
Start date
2020-02-15
Completion date
2022-02-15
Last updated
2020-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Colorectal Cancer, ERAS, Single Incision plus one, Laparoscopic surgery

Brief summary

Conventional laparoscopic surgery (CLS) for colorectal cancer has been demonstrated to be safe and feasible and present minimally invasive benefits including faster recovery, reduced postoperative pain and shorter hospital stay, also acquiring comparable oncologic outcomes with open surgery. To achieve further minimally invasive outcomes, SILS plus one port surgery was attempted by some surgeons. Preliminary results showed that SILS+1 could achieve better minimally invasive benefits than CLS while preserving oncologic feasibility. Till now, ERAS has been practiced in colorectal cancer surgery for approximately 20 years. Studies have proven that ERAS is safe and significantly improved the recovery course of patients during perioperative period, meanwhile, the expense could be greatly reduced. Based on ERAS studies protocols and SILS+1 trials, investigators tried to combine SILS+1 with ERAS, hopefully to provide patients with more safe, economic, feasible and rapid surgery and perioperative strategies.

Interventions

COMBINATION_PRODUCTSingle incision plus one port laparoscopic surgery

SILS plus one port surgery and enhanced recovery after surgery protocol both are methods taking the minimally invasive benefits for the patients including faster recovery, reduced postoperative pain and shorter hospital stay.

Sponsors

Nanfang Hospital, Southern Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Primary tumor diagnosed as adenocarcinoma confirmed pathologically by endoscopic biopsy * cT1-4a, N0-3, M0 at preoperative evaluation according to the AJCC Cancer Staging Manual Seventh Edition * Located in the cecum, ascending colon, transverse colon, descending colon, sigmoid colon, the upper segment of the rectum. * Diameter ≦ 5cm * No severe organ dysfunction * Performance status of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale * ASA (American Society of Anesthesiology) score class I or II * Written informed consent

Exclusion criteria

* Unsuitable for patients undergoing single incision plus one port laparoscopic surgery * Patients with Complications caused by colorectal cancer ( bleeding , perforation, obstruction or incomplete obstruction ) * Previous abdominal surgery * Malignant diseases within the past 5years * Requirements of simultaneous surgery for another diseases

Design outcomes

Primary

MeasureTime frameDescription
Rehabilitative rate4 daysThe percentage of patients who met discharge criteria in the fourth day after surgery
Postoperative hospital stays1 monthDays from surgery to discharge

Secondary

MeasureTime frameDescription
Postoperative recovery index1 monthThe first Time to early mobilization(hour), flatus(hour), liquid diet(hour), soft diet(hour), removal of the Nasogastric tubes(hour) , removal of the peritoneal drainage(hour) are used to assess the postoperative recovery
Postoperative inflammatory immune response3 daysIt includes the number of white blood cells and lymphocytes,CRP, IL-6
compliance with ERAS measuresperioperativeIt is defined as if the patients complete every ERAS measure or not. We can defined it yes or not.
Medical cost1 monthThe patient's expenses from surgery to discharge are recorded in RMB yuan
hospital readmissions30daysIt can be defined as the number of patients readmitted within 30 days because of postoperative complications.
Morbidity and mortality rates30 daysMorbidity and mortality rates are defined as postoperative complications graded according to Clavien-Dindo within 30 days.
6 min postoperative walking test(6MWT)Once a day from the frist to the fourth day after surgeryStudy site, subject preparation, trial procedures, and medical monitoring refer to the 6MWT guidelines issued by the American thoracic society in 2002.
Postoperative pain scoreOnce a day from 6 hours to the fourth day after surgeryPostoperative pain is recorded using the visual analog scale (VAS) pain score tool on postoperative day . On a scale of 1 to 10, the higher the score, the greater the pain.

Contacts

Primary ContactWang Yanan, M.D
wyn8116@163.com+86-131-8909-6629

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026